Walker & Dunlop, Inc. - Form 8-K Summary
Business Context and Reporting Period
Walker & Dunlop, Inc. (WD) filed a Current Report on Form 8-K dated March 14, 2025. The filing details the completion of a significant capital restructuring involving the issuance of new senior unsecured notes and the amendment of its existing credit facilities. The company is a Maryland corporation with principal executive offices in Bethesda, MD.
Key Financial Metrics and Capital Structure
The filing focuses on debt issuance and refinancing rather than operating performance metrics such as revenue or profit, which are not disclosed in this document.
- Senior Unsecured Notes: Issued $400 million aggregate principal amount due 2033.
- Interest Rate (Notes): Fixed at 6.625% per annum, payable semiannually.
- Term Loan Facility: Established a new $450 million term loan facility.
- Revolving Credit Facility: Established a new $50 million revolving credit facility.
- Refinancing Target: Proceeds used to refinance and reduce a prior $800 million term loan.
- Financial Covenants: The new Credit Agreement requires an Asset Coverage Ratio of at least 1.50 to 1.00.
Material Changes Versus Prior Period
The company executed a comprehensive refinancing of its senior debt structure:
- Debt Replacement: Replaced the prior $800 million term loan (originated December 2021) with a new $450 million term loan and $400 million in senior notes.
- Interest Rate Structure: The new Term Loan bears interest at Alternate Base Rate + 1.00% or Term SOFR + 2.00% (subject to a 0.25% reduction if leverage is ≤ 2.00x). The Revolving Credit Facility bears interest at Alternate Base Rate + 0.75% or SOFR + 1.75%.
- Maturity Extension: The new Notes mature on April 1, 2033, and the Term Loan matures on March 14, 2032, extending the company's debt maturity profile.
- Amendments to Existing Agreements: Amended the Master Repurchase Agreement and Warehousing Credit Agreement to permit subsidiaries to guarantee the new Notes and Credit Agreement.
Guidance, Outlook, and Risks
Management Commentary and Use of Proceeds: Proceeds from the Notes and Term Loan were utilized to refinance the Prior Term Loan and for general corporate purposes. Revolving Credit Facility proceeds are designated for general corporate purposes and working capital.
Redemption Terms:
- Notes may be redeemed prior to April 1, 2028, at a "make-whole" premium.
- Up to 40% of Notes may be redeemed with equity offering proceeds at 106.625% of principal prior to April 1, 2028.
- Notes may be redeemed at declining premiums (103.313%, 101.656%) between 2028 and 2030, and at 100% thereafter.
Risks and Covenants:
- Covenants: The Indenture and Credit Agreement impose restrictions on restricted payments, dividends, additional indebtedness, asset dispositions, and mergers.
- Change of Control: A Change of Control triggers a mandatory repurchase offer for the Notes at 101% of principal plus accrued interest.
- Events of Default: Include non-payment, covenant breaches, cross-defaults, and bankruptcy proceedings.
Investor Verification Checklist
- Verify the exact amount of the "Prior Term Loan" remaining after the refinancing to confirm the net reduction in debt.
- Review the full text of the Indenture (Exhibit 4.1) and Credit Agreement (Exhibit 10.1) for specific definitions of "Consolidated Adjusted EBITDA" and "Asset Coverage Ratio."
- Confirm the company's current leverage ratio to determine if the 0.25% interest rate reduction on the Term Loan is currently applicable.
- Assess the impact of the 6.625% fixed interest rate on the Notes relative to current market rates and the company's cost of capital.
- Check for any subsequent filings regarding the utilization of the $50 million Revolving Credit Facility.